HEOR evidence review for market access and regulatory consultants
Compare interventions, map the trial evidence and hand clients deliverables in which every statement points to an NCT number or PMID.
Evidence work in HEOR and market access consulting
Health economics and outcomes research, market access and regulatory consultants work to client deadlines. A payer dossier needs the clinical evidence for the product and its comparators. A health technology assessment submission needs to show which trials exist, how they compare and where the gaps are. A regulatory strategy memo needs a quick read of what similar products have been studied against.
Each project starts with the same heavy lift: searching registries and the literature, reading trial records and publications, building comparison tables and checking every reference before the deliverable reaches the client. Time spent on retrieval is time not spent on analysis, and an unchecked reference in a client document damages trust.
- Comparator choices drive the value story in a dossier
- Clients expect references they can open and check
- Each new project repeats the same retrieval steps
- Deliverables need tables and reference lists in client formats
A typical HEOR evidence review workflow
-
1. Ask the comparison question, for example how biologics for moderate to severe plaque psoriasis compare across head to head and placebo controlled phase 3 trials.
-
2. Run an intervention comparison of two to four treatments to get a side by side table of trials, populations, endpoints and posted outcomes, with citations on every row.
-
3. Open the trial table and filter by phase, status, date range, country and results available to define the evidence base for the project.
-
4. Build an evidence summary that labels the level of evidence for each cited source.
-
5. Share the thread with colleagues in a project workspace and comment on what goes into the deliverable.
-
6. Export the comparison to XLSX for the analysis team and to DOCX with a reference list for the client report.
-
ClinicalEvidence gives you the cited evidence base. Network meta-analysis, cost effectiveness models and the final HTA argument stay with your team, and their conclusions are yours.
Features that matter for consultants
- Intervention comparisons for two to four treatments, counted as 5 cited answers each
- Cited answers verified against the index before display
- A clinical trial table with endpoints, populations, sponsors and results posted
- Export to XLSX, DOCX with reference list, CSV, RIS and BibTeX
- Shared workspaces with roles, so client projects stay separate
- Invoicing on Organization and Enterprise for the finance team
For literature heavy projects, see the AI literature review workflow.
Recommended plan for HEOR and market access consultants
Research Team costs 199 USD per month, or 99 USD per month billed yearly (1 188 USD). It includes 800 cited answers per month pooled across 3 seats, up to 100 per day, trial tables of up to 200 studies, 25 alerts, XLSX and DOCX export and shared workspaces.
A consultancy with several project teams chooses Organization at 499 USD per month, or 249 USD per month billed yearly (2 988 USD), with 2 000 cited answers pooled across 10 seats, trial tables of up to 500 studies, 100 alerts, bulk CSV export, an audit log and invoicing. All plans are on the pricing page.
Questions from consultants
Can I use exports in client deliverables?
Yes. Exports to XLSX and DOCX with a reference list are made to drop into your own report and dossier templates, and each reference links back to the public source record.
How are intervention comparisons counted?
One comparison of two to four interventions counts as 5 cited answers, because it reads and verifies many more studies than a single question.
Does ClinicalEvidence run a network meta-analysis?
No. It finds, compares and cites the trials and publications. Statistical synthesis and economic modelling stay with your analysts.
Start your next dossier with a cited evidence base
Create your account and run your first intervention comparison today.